The FDA has recently updated an earlier Public Health Advisory concerning Gadolinium-based MRI Contrast Agents which are drugs injected into patients in Magnetic Resonance Imaging (MRI) and Magnetic Resonance Angiography (MRA) procedures.
Spangenberg, Shibley & Liber is continuing to operate with the health
and safety of our employees and clients as a top priority, but we are
available for phone conferences and via email.
Please do not hesitate to reach out to us.